CLASS II Drug recall · Reported 8 Jul 2020 · FDA Enforcement Report

Childrens Robitussin Honey Cough and Chest Congestion DM recalled

Glaxosmithkline Consumer Healthcare Holdings is recalling Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough, distributed nationwide in the US. The recall was initiated on 16 Jun 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #s: 02177, 02178, Exp. 01/31/2022
NDC0031-8760
Quantity recalled132,336 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1361-2020
FDA event ID
85848
Manufacturer
Haleon US Holdings LLC
Classification
Class II
Status
Terminated
Recall initiated
16 Jun 2020
FDA classified
26 Jun 2020
Reported
8 Jul 2020
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Other Reasons

Timeline

16 Jun 2020Recall initiated by company
26 Jun 2020Classified by FDA+10 days
8 Jul 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.

Product as listed by the FDA

Childrens Robitussin Honey Cough and Chest Congestion DM, dextromethorphan (cough suppressant), guaifenesin (expectorant), 4 FL OZ. bottle (118 mL), Distributed by: Pfizer, Madison, NJ 07940 USA, UPC: 50300318760128, NDC: 0031-8760-12.

Where it was distributed

Nationwide in the US

Nationwide

Questions about this recall

Why was it recalled?

Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.

Which lots are affected?

Lot #s: 02177, 02178, Exp. 01/31/2022

Where was it sold?

Nationwide in the US

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 85848

This product is part of a recall event; the main page for the event is Childrens Dimetapp Cold & Cough, For ages 6 yrs recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIChildrens Dimetapp Cold & Cough, For ages 6 yrs recalledGlaxosmithkline Consumer Healthcare HoldingsOtherNationwide

More recalls from Glaxosmithkline Consumer Healthcare Holdings

All 26

Other Dextromethorphan Hbr recalls

All 6
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIKids' Cough and Chest Congestion (Dextromethorphan HBr recalledMaximum Strength Cough And Chest Congestion And Nighttime Severe Cold And Flu Combo PackDenison PharmaceuticalsPackaging DefectsRI
DrugCLASS IIIAdult Cough and Chest Congestion recalled by Denison PharmaceuticalsMaximum Strength Cough And Chest Congestion And Nighttime Severe Cold And Flu Combo PackDenison PharmaceuticalsPackaging DefectsRI
DrugCLASS IIRompe Pecho DM recalled by Efficient LaboratoriesRompe PechoEfficient LaboratoriesSterilityNationwide
DrugCLASS IIRompe Pecho CF Cold & Flu Advanced Formula recalledRompe PechoEfficient LaboratoriesSterilityNationwide
DrugCLASS IPecgen DMX Cough Suppressant Expectorant recalled by Novis PRPecgen DmxNovis PROtherPR